T

tuko.co.ke

@tuko 21 hours ago

Pfizer profits dip on lower Paxlovid sales

Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects. Sales of Paxlovid slid 75 percent amid lower Covid-19 infections and reduced government purchases of the medication.

read more

Other Headlines